BioSpecifics Technologies Corp. Announces Positive Data from Phase 2b Study of CCH in Patients...
BioSpecifics Technologies Corp , a biopharmaceutical company that originated and continues to develop collagenase based-therapies...
Bristol-Myers Squibb and Enterome Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and...
Bristol-Myers Squibb Company and Enterome, a pioneer in the development of pharmaceuticals and diagnostics based...
Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma
Cytori Therapeutics, Inc. announced that the US FDA Office of Orphan Products Development (OOPD) has...
Bristol-Myers Squibb Enters into New Collaboration with Johns Hopkins Focused on Immuno-Oncology Research
Bristol-Myers Squibb Company announced that the company has entered into a five-year research collaboration with...
AdAlta licenses Alzheimer’s disease-specific shark antibodies to Crossbeta Biosciences for therapeutic and diagnostic development
AdAlta Limited a biotechnology company specialising in the discovery and development of protein-based therapeutics, and...
Lonza Holds Grand Opening for State-of-the-Art Drug Product Services Labs
Lonza, a global leader in chemical and biological manufacturing, held the grand opening of its...
Takara Bio USA Inc to Supply Single-Cell RNA-Seq Kit for the Allen Cell Types...
Takara Bio USA Inc announced that its SMART-Seq v4 Ultra Low Input RNA Kit for...
Sun Pharma Announces US Launch of Authorized Generics for Benicar®, Benicar HCT® , Azor®...
Sun Pharmaceutical Industries Ltd announced that its wholly owned subsidiary has launched in US, the...
Antihypertensive drug Micatrio combination tablets launch in Japan
Nippon Boehringer Ingelheim Co., Ltd. and Astellas Pharma Inc. announced that the companies have newly...
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Teva Pharmaceutical Industries Ltd and Celltrion Healthcare announce that the companies have entered into an...
